Skip to main content
. Author manuscript; available in PMC: 2022 Mar 18.
Published in final edited form as: Laryngoscope. 2019 Apr 7;130(1):94–100. doi: 10.1002/lary.27856

Table 2.

Patient demographics, clinical characteristics, and swallow outcomes.

All n(%) Acceptable Swallowing n(%) Poor Swallowing n(%) OR Ɨ 95% CIǂ
Age (years)
 Mean (SD) 59.4 (9.2) 58.0 (9.2) 62.5 (8.3) 1.06 1.00–1.12

Age (dichotomous)
 Less than 60 45 (55) 34 (61) 11 (42)
 60 or Greater 37 (45) 22 (39) 15 (58) 2.11 0.82–5.42

Gender
 Male 74 (90) 50 (89) 24 (92)
 Female 8 (10) 6 (11) 2 (8) 0.69 0.13–3.70

Smoking
 Never 31 (38) 23 (41) 8 (30)
 Past 33 (40) 24 (43) 9 (35) 1.08 0.36–3.27
 Current 18 (22) 9 (16) 9 (35) 2.88 0.84–9.79

Smoking
 Never 31 (38) 23 (41) 8 (31)
 Past or Current Smoker 51 (62) 33 (59) 18 (69) 1.57 0.58–4.21

ACE
 0 (None) 33 (40) 24 (43) 9 (35)
 1 (Mild) 40 (49) 26 (46) 14 (54) 1.44 0.53–3.92
 2 (Moderate) 7 (9) 4 (7) 3 (11) 2.00 0.37–10.75
 3 (Severe) 2 (2) 2 (4) 0 (0) NA NA

ACE
 None 33 (40) 24 (43) 9 (35)
 Comorbidities Present 49 (60) 32 (57) 17 (65) 1.42 0.54–3.72

Site (Consolidated)
 BOT 42 (51) 26 (46) 16 (62)
 Tonsil 40 (49) 30 (54) 10 (38) 0.54 0.21–1.40

Tumor Histology
 Well-differentiated 0 (0) 0 (0) 0 (0)
 Moderately differentiated 9 (11) 4 (7) 5 (20)
 Poorly differentiated 16 (20) 10 (19) 6 (24) 0.48 0.09–2.52
 Non-keratinizing 48 (61) 36 (67) 12 (48) 0.27 0.06–1.16
 Other 6 (8) 4 (7) 2 (8) 0.40 0.05–3.42
 Missing 3

pT Pathologic Tumor Stage (AJCC 7th ed.)
 T3 45 (55) 35 (63) 10 (38)
 T4a, T4b 37 (45) 21 (37) 16 (62) 2.67 1.02–6.95

pN Pathologic Nodal Stage (AJCC 7th ed.)
 N0 12 (15) 11 (20) 1 (4)
 N1 7 (9) 5 (9) 2 (8) 4.40 0.32–60.61
 N2a 9 (11) 8 (14) 1 (4) 1.38 0.07–25.43
 N2b 30 (37) 21 (37) 9 (36) 4.71 0.53–42.17
 N2c 21 (26) 9 (16) 12 (48) 14.67 1.59–135.32
 N3 2 (2) 2 (4) 0 (0) NA NA
 Missing 1

pStage Pathologic Stage (AJCC 7th ed.)
 I, II, III 9 (11) 8 (15) 1 (4)
 IVA, IVB 71 (89) 46 (85) 25 (96) 4.35 0.51–36.78
 Missing 2

Type of Surgical Treatment
 TLM 74 (90) 48 (86) 26 (100)
 TORS 4 (5) 4 (7) 0 (0) NA NA
 Loupes 4 (5) 4 (7) 0 (0) NA NA

BOT Resection
 0–49% Resection 53 (65) 41 (73) 12 (46)
 ≥50% Resection 29 (35) 15 (27) 14 (54) 3.19 1.21–8.43

Lateral Pharynx/Tonsil Resection
 None to Parapharyngeal Fat Exposure 73 (89) 49 (88) 24 (92)
 Exposed Carotid 9 (11) 7 (12) 2 (8) 0.58 0.11–3.02

Soft Palate Resection
 0–49% Resection 77 (94) 53 (95) 24 (92)
 ≥50% Resection 5 (6) 3 (5) 2 (8) NA NA

Neck Dissection
 None 4 (5) 3 (6) 1 (4)
 Ipsilateral 40 (49) 31 (55) 9 (35) 0.87 0.08–9.43
 Bilateral 38 (46) 22 (39) 16 (61) 2.18 0.21–22.95

Neck Dissection
 None or Ipsilateral 44 (54) 34 (61) 10 (38)
 Bilateral 38 (46) 22 (39) 16 (62) 2.47 0.95–6.43

CNX Resection
 None 81 (99) 56 (100) 25 (96)
 Performed 1 (1) 0 (0) 1 (4) NA NA

CNXII Resection
 None 73 (89) 51 (91) 22 (85)
 Performed 9 (11) 5 (9) 4 (15) NA NA

Lingual Nerve Resection
 None 71 (87) 49 (88) 22 (85)
 Performed 11 (13) 7 (12) 4 (15) 1.27 0.34–4.80

Pterygoid Resection
 None 68 (83) 44 (79) 24 (92)
 Performed 14 (17) 12 (21) 2 (8) 0.31 0.06–1.48

Type of Reconstruction
 None, Local Flap, or Other 75 (92) 52 (93) 23 (89)
 Regional or Free Flap 7 (8) 4 (7) 3 (11) NA NA

Pharyngotomy
 None 47 (57) 34 (61) 13 (50)
 Performed 35 (43) 22 (39) 13 (50) 1.55 0.61–3.95

p16
 Negative 5 (6) 4 (7) 1 (4)
 Positive 74 (94) 51 (93) 23 (96) 1.80 0.19–17.05
 Missing 3

Adjuvant Therapy
 None or Radiation Only 37 (47) 29 (54) 8 (32)
 Chemoradiation Therapy 42 (53) 25 (46) 17 (68) 2.47 0.91–6.68
 Missing 3

Recurrence (Any)
 None 60 (73) 43 (77) 17 (65)
 Present 22 (27) 13 (23) 9 (35) 1.75 0.63–4.85

Recurrence (Local or Regional)
 None or Distant 71 (87) 48 (86) 23 (89)
 Local or Regional 11 (13) 8 (14) 3 (11) 0.78 0.19–3.23

Long-term Tracheostomy, 1 year follow-up
 No 77 (94) 55 (98) 22 (85)
 Yes 5 (6) 1 (2) 4 (15) 10.00 1.06–94.54

Trismus, 1 year follow-up
 No 65 (79) 46 (82) 19 (73)
 Yes 17 (21) 10 (18) 7 (27) 1.70 0.56–5.11
Ɨ

OR = Odds Ratio

ǂ

CI = Confidence Interval